Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lacave

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
La Revue De Medecine Interne|January 1, 1994
[Recurrent metabolic encephalopathy, self-administered gastric lavage and Munchausen syndrome]M Strobel, J Chevallier, B de la Vareille, et al.
Expert Review of Anticancer Therapy|June 24, 2014
Challenges in first line chemotherapy and targeted therapy in advanced gastric cancerMarcelo Garrido, Paula J Fonseca, Jose María Vieitez, et al.
Bulletin De La Societe De Pathologie Exotique (1990)|January 1, 1990
[Follow-up of HIV-I seropositive children at the Saint-Hyacinthe Hospital in Basse-Terre (Guadeloupe)]J P Arnaud, G Sibille, J Nguyen, et al.
American Journal of Clinical Oncology|October 1, 1989
120 hours simultaneous infusion of cisplatin and fluorouracil in metastatic breast cancerO Fernández Hidalgo, F González, A Gil, et al.
Cancer Clinical Trials|January 1, 1978
Phase I and II clinical study of anhydro-ara-5-fluorocytosine (AAFC) and ICRF-159 combination in adenocarcinoma of digestive originA Brugarolas, J M Buesa, A J Lacave, et al.
European Journal of Cancer|March 1, 1979
Results of two sequential chemotherapy studies in WHO Types I, III and IV lung cancer: cyclophosphamide-5-fluorouracil (CF) and cyclophosphamide-5-fluorouracil-adriamycin (CAF)A Brugarolas, A J Lacave, A Ribas, et al.
Cancer Treatment Reports|March 1, 1984
Phase I trial of intermittent high-dose dacarbazineJ M Buesa, M Gracia, M Valle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2001
Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecanA N Gordon, J T Fleagle, D Guthrie, et al.
Cancer Treatment Reports|October 1, 1978
Phase I clinical study of quelamycinA Brugarolas, N Pachon, M Gosalvez, et al.
Mutagenesis|September 19, 2012
Long-term biomonitoring of breast cancer patients under adjuvant chemotherapy: the comet assay as a possible predictive factorE Uriol, M Sierra, M A Comendador, et al.
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
La Revue De Medecine Interne|January 1, 1994
[Recurrent metabolic encephalopathy, self-administered gastric lavage and Munchausen syndrome]M Strobel, J Chevallier, B de la Vareille, et al.
Expert Review of Anticancer Therapy|June 24, 2014
Challenges in first line chemotherapy and targeted therapy in advanced gastric cancerMarcelo Garrido, Paula J Fonseca, Jose María Vieitez, et al.
Bulletin De La Societe De Pathologie Exotique (1990)|January 1, 1990
[Follow-up of HIV-I seropositive children at the Saint-Hyacinthe Hospital in Basse-Terre (Guadeloupe)]J P Arnaud, G Sibille, J Nguyen, et al.
American Journal of Clinical Oncology|October 1, 1989
120 hours simultaneous infusion of cisplatin and fluorouracil in metastatic breast cancerO Fernández Hidalgo, F González, A Gil, et al.
Cancer Clinical Trials|January 1, 1978
Phase I and II clinical study of anhydro-ara-5-fluorocytosine (AAFC) and ICRF-159 combination in adenocarcinoma of digestive originA Brugarolas, J M Buesa, A J Lacave, et al.
European Journal of Cancer|March 1, 1979
Results of two sequential chemotherapy studies in WHO Types I, III and IV lung cancer: cyclophosphamide-5-fluorouracil (CF) and cyclophosphamide-5-fluorouracil-adriamycin (CAF)A Brugarolas, A J Lacave, A Ribas, et al.
Cancer Treatment Reports|March 1, 1984
Phase I trial of intermittent high-dose dacarbazineJ M Buesa, M Gracia, M Valle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2001
Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecanA N Gordon, J T Fleagle, D Guthrie, et al.
Cancer Treatment Reports|October 1, 1978
Phase I clinical study of quelamycinA Brugarolas, N Pachon, M Gosalvez, et al.
Mutagenesis|September 19, 2012
Long-term biomonitoring of breast cancer patients under adjuvant chemotherapy: the comet assay as a possible predictive factorE Uriol, M Sierra, M A Comendador, et al.
Pageof 7